Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T Cells
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-3163
Full Text
Open PDFAbstract
Available in full text
Date
September 8, 2009
Authors
Publisher
American Association for Cancer Research (AACR)